Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
life sciences
4
×
national blog main
biotech
cancer
national
boston blog main
boston top stories
bristol-myers squibb
cancer immunotherapy
national top stories
new york blog main
new york top stories
novartis
samit hirawat
san francisco blog main
san francisco top stories
amgen
bill &
boulder/denver blog main
boulder/denver top stories
cholesterol
clinical trials
data
democrats
detroit blog main
detroit top stories
donald trump
drug price
h.r. 3
house
hr 3
inclisiran
indiana blog main
indiana top stories
insulin
insurance
ldl
legislation
lower
mark timney
What
year
4
×
acquisition
anniversary
approaches
bn
bristol
celgene
chief
clinical
company’s
corporation
diversity
hirawat
medical
myers
myers’s
officer
pipeline
progress
scrip
spoke
squibb
trial
aces
announced
answer
away
big
ceo
cholesterol
democratic
dems
discontent
drug
drugs
election
flexible
high
house
inclisiran
Language
unset
4
×
Current search:
year
×
unset
×
" life sciences "
×
@xconomy.com
3 years ago
Bristol Myers’s Hirawat on Pipeline Progress, Clinical Trial Diversity
@xconomy.com
3 years ago
Bristol Myers’s Hirawat on Pipeline Progress, Clinical Trial Diversity
@xconomy.com
4 years ago
Pelosi, Dems Unveil Price Plan: Are 25 Drugs Enough for Negotiation?
@xconomy.com
4 years ago
As Cholesterol Drug Aces Big Test, MedCo CEO Open to Flexible Pricing
